Thiazoloindolinone compounds
US6492398B1 · kind B1 · utility
6Cited by
15References
50Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 28, 2001 |
| Grant date | Dec 10, 2002 |
| Priority date | — |
| Expiry date | Aug 28, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Thiazole-indole compounds useful as cyclin dependent kinase 11 inhibitors, for preventing/reducing the severity of epithelial cytotoxicity side-effects (e.g., alopecia, plantar-palmar syndrome, mucositis) induced by chemoptherapy and/or radiation therapy in a patient receiving such therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.